Nilotinib Plus Dabrafenib/Trametinib in Metastatic Melanoma

Conditions:   Metastatic Melanoma;   BRAF Gene Mutation Interventions:   Drug: Nilotinib 100mg;   Drug: Nilotinib 200mg;   Drug: Nilotinib 300mg;   Drug: Nilotinib 400mg;   Drug: Dabrafenib;   Drug: Trametinib Sponsor:   Peng Wang, MD PhD Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials